Mayank Gandhi - Sep 26, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Chief Business Officer
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Mayank Gandhi
Stock symbol
EFTR
Transactions as of
Sep 26, 2022
Transactions value $
$0
Form type
4
Date filed
9/28/2022, 04:47 PM
Next filing
Jan 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +500K $0.00 500K Sep 26, 2022 Common Stock 500K $0.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 25% on September 26, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.